X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (5019) 5019
Book Review (915) 915
Book / eBook (246) 246
Publication (205) 205
Magazine Article (20) 20
Book Chapter (9) 9
Conference Proceeding (8) 8
Dissertation (1) 1
Presentation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (4600) 4600
humans (4337) 4337
gastrointestinal hemorrhage - chemically induced (3210) 3210
male (2713) 2713
female (2243) 2243
aged (1596) 1596
middle aged (1595) 1595
anti-inflammatory agents, non-steroidal - adverse effects (1205) 1205
adult (1182) 1182
abridged index medicus (1088) 1088
aspirin - adverse effects (967) 967
animals (927) 927
risk factors (916) 916
gastroenterology & hepatology (726) 726
nonsteroidal antiinflammatory drugs (602) 602
gastrointestinal diseases - chemically induced (577) 577
aged, 80 and over (562) 562
pharmacology & pharmacy (520) 520
aspirin (515) 515
anticoagulants - adverse effects (508) 508
medicine, general & internal (502) 502
risk (491) 491
rats (481) 481
gastrointestinal hemorrhage - prevention & control (454) 454
platelet aggregation inhibitors - adverse effects (389) 389
gastrointestinal diseases (388) 388
gastric mucosa - drug effects (381) 381
retrospective studies (380) 380
aspirin - administration & dosage (358) 358
gastrointestinal hemorrhage - etiology (340) 340
treatment outcome (340) 340
gastrointestinal hemorrhage - epidemiology (331) 331
dose-response relationship, drug (318) 318
hemorrhage (316) 316
anti-inflammatory agents, non-steroidal - therapeutic use (311) 311
stomach ulcer - chemically induced (305) 305
time factors (299) 299
gastrointestinal bleeding (298) 298
prevention (292) 292
adolescent (291) 291
peptic ulcer - chemically induced (287) 287
rheumatoid-arthritis (280) 280
gastrointestinal hemorrhage - diagnosis (278) 278
nonsteroidal anti-inflammatory drugs (272) 272
therapy (266) 266
gastrointestinal system (249) 249
medicine & public health (249) 249
anti-inflammatory agents, non-steroidal - administration & dosage (247) 247
risk assessment (242) 242
aspirin - therapeutic use (236) 236
drug interactions (234) 234
drug therapy (233) 233
drug therapy, combination (229) 229
incidence (224) 224
administration, oral (223) 223
gastrointestinal hemorrhage - drug therapy (222) 222
low-dose aspirin (221) 221
surgery (217) 217
oncology (215) 215
care and treatment (214) 214
double-blind (211) 211
warfarin - adverse effects (211) 211
gastrointestinal hemorrhage - therapy (210) 210
gastroenterology (208) 208
hemorrhage - chemically induced (208) 208
proton pump inhibitors (206) 206
anticoagulants (202) 202
gastric mucosa - pathology (202) 202
prospective studies (194) 194
mice (193) 193
complications (189) 189
analysis (185) 185
complications and side effects (184) 184
cyclooxygenase inhibitors - adverse effects (184) 184
double-blind method (184) 184
gastroenterology and hepatology (180) 180
bleeding (175) 175
platelet aggregation inhibitors - therapeutic use (174) 174
gastrointestinal hemorrhage - pathology (173) 173
case-control studies (170) 170
mortality (170) 170
warfarin (168) 168
health aspects (167) 167
ticlopidine - analogs & derivatives (167) 167
digestive system (166) 166
acute disease (165) 165
diseases (164) 164
age factors (162) 162
endoscopy (162) 162
cancer (161) 161
ulcers (160) 160
platelet aggregation inhibitors - administration & dosage (159) 159
proton pump inhibitors - therapeutic use (159) 159
cohort studies (157) 157
child (154) 154
research (153) 153
colitis - chemically induced (150) 150
drugs (150) 150
anti-ulcer agents - therapeutic use (149) 149
anticoagulants - administration & dosage (149) 149
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (216) 216
Scarborough Hospital - General (7) 7
Collection Dvlpm't (Acquisitions) - Closed Orders (6) 6
St. Michael's Hospital - Stacks (6) 6
Lakeridge Health Sciences - Oshawa (5) 5
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (4) 4
Collection Dvlpm't (Acquisitions) - Vendor file (3) 3
Providence Healthcare - Stacks (3) 3
Toronto East General Hospital - Stacks (3) 3
Baycrest Hospital - Stacks (2) 2
Credit Valley Hospital - Reference (2) 2
Gerstein Science - Reference (2) 2
Humber River Regional Hospital - Church Stacks (2) 2
Markham Stouffville Hospital - Stacks (2) 2
Providence Healthcare - Reference (2) 2
Scarborough Hospital - Birchmount (2) 2
Toronto East General Hospital - Online (2) 2
Trillium Health Centre - Stacks (2) 2
Church Stacks (1) 1
Credit Valley Hospital - Stacks (1) 1
Humber River Regional Hospital - Finch Stacks (1) 1
Humber River Regional Hospital - Pharmacy (1) 1
Mt Sinai Hospital - Pathology (1) 1
Mt Sinai Hospital - Stacks (1) 1
Online Resources - Online (1) 1
St Josephs Health Centre - Stacks (1) 1
St. Michael's Hospital - Circulation Desk (1) 1
Thomas Fisher Rare Book - Rare Book (1) 1
UTL at Downsview - May be requested (1) 1
UofT at Mississauga - Oversize (1) 1
UofT at Mississauga - Reference (1) 1
UofT at Mississauga - Stacks (1) 1
West Park Healthcare Centre - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (4558) 4558
French (165) 165
German (163) 163
Spanish (102) 102
Russian (51) 51
Japanese (48) 48
Italian (41) 41
Dutch (21) 21
Swedish (20) 20
Polish (19) 19
Danish (17) 17
Norwegian (17) 17
Hungarian (12) 12
Czech (11) 11
Chinese (10) 10
Korean (8) 8
Hebrew (6) 6
Portuguese (6) 6
Serbian (5) 5
Slovak (5) 5
Romanian (3) 3
Turkish (3) 3
Bulgarian (2) 2
Finnish (2) 2
Ukrainian (2) 2
Arabic (1) 1
Bosnian (1) 1
Croatian (1) 1
Lithuanian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 09/2016, Volume 375, Issue 12, pp. 1131 - 1141
Journal Article
Circulation, ISSN 0009-7322, 2015, Volume 131, Issue 2, pp. 157 - 164
Background-The comparative safety of dabigatran versus warfarin for treatment of nonvalvular atrial fibrillation in general practice settings has not been... 
anticoagulant | thrombin inhibitor | safety | pharmacoepidemiology | warfarin | DIAGNOSIS | CARDIAC & CARDIOVASCULAR SYSTEMS | METAANALYSIS | ADMINISTRATIVE DATA | VALIDATION | OLDER | CODING ACCURACY | STROKE | THERAPY | ACUTE MYOCARDIAL-INFARCTION | PERIPHERAL VASCULAR DISEASE | POSITIVE PREDICTIVE-VALUE | Anticoagulants - administration & dosage | Follow-Up Studies | United States | Humans | Medicare - statistics & numerical data | Warfarin - adverse effects | Risk | Dabigatran | Gastrointestinal Hemorrhage - epidemiology | Socioeconomic Factors | Warfarin - therapeutic use | Dose-Response Relationship, Drug | Benzimidazoles - administration & dosage | Kidney Diseases - epidemiology | Aged, 80 and over | Retrospective Studies | Benzimidazoles - adverse effects | beta-Alanine - analogs & derivatives | Benzimidazoles - therapeutic use | Stroke - prevention & control | beta-Alanine - adverse effects | Hemorrhage - epidemiology | Atrial Fibrillation - drug therapy | Comorbidity | Atrial Fibrillation - complications | Kaplan-Meier Estimate | Proportional Hazards Models | beta-Alanine - administration & dosage | beta-Alanine - therapeutic use | Anticoagulants - therapeutic use | Treatment Outcome | Anti-Arrhythmia Agents - therapeutic use | Anticoagulants - adverse effects | Gastrointestinal Hemorrhage - chemically induced | Stroke - etiology | Intracranial Hemorrhages - chemically induced | Intracranial Hemorrhages - epidemiology | Aged | Hemorrhage - chemically induced | Complications and side effects | Warfarin | Atrial fibrillation | Aged patients | Dabigatran etexilate | Dosage and administration | Comparative analysis | Drug therapy | Health aspects | Hemorrhage | Risk factors | Index Medicus | Abridged Index Medicus
Journal Article
Journal Article
Gastroenterology, ISSN 0016-5085, 2011, Volume 141, Issue 4, pp. 1314 - 1322.e5
Background & Aims Proton pump inhibitors (PPIs) and nonsteroidal anti-inflammatory drugs (NSAIDs) are among the most commonly used classes of drugs, with the... 
Gastroenterology and Hepatology | Ulcer | Microflora | Bleeding | Acid Secretion | ULCERS | NONSTEROIDAL ANTIINFLAMMATORY DRUG | PERMEABILITY | RATS | INDOMETHACIN | LEUKOCYTE ADHERENCE | INDUCED GASTRIC DAMAGE | PATHOGENESIS | NITRIC-OXIDE | BACTERIAL OVERGROWTH | GASTROENTEROLOGY & HEPATOLOGY | Jejunum - pathology | Rats, Wistar | Colon - drug effects | Hematocrit | Peptic Ulcer - prevention & control | Male | Omeprazole - toxicity | Bifidobacterium - isolation & purification | Bifidobacterium - growth & development | Actinobacteria - drug effects | Jejunum - drug effects | Drug Interactions | Peptic Ulcer - microbiology | Time Factors | Actinobacteria - genetics | Actinobacteria - isolation & purification | Disease Models, Animal | Bifidobacterium - genetics | Jejunum - microbiology | Rats | Celecoxib | Probiotics - pharmacology | Reverse Transcriptase Polymerase Chain Reaction | Proton Pump Inhibitors - toxicity | Anti-Inflammatory Agents, Non-Steroidal - toxicity | Peptic Ulcer - pathology | Denaturing Gradient Gel Electrophoresis | 2-Pyridinylmethylsulfinylbenzimidazoles - toxicity | Gastrointestinal Hemorrhage - chemically induced | Gastrointestinal Hemorrhage - prevention & control | Bifidobacterium - drug effects | Animals | Gastrointestinal Hemorrhage - microbiology | Actinobacteria - growth & development | Pyrazoles - toxicity | Anti-Inflammatory Agents, Non-Steroidal - pharmacokinetics | Naproxen - toxicity | Sulfonamides - toxicity | Colon - microbiology | Peptic Ulcer - chemically induced | Gastrointestinal Hemorrhage - pathology | Lansoprazole | Proton pump inhibitors | Messenger RNA | Nonsteroidal anti-inflammatory drugs | Index Medicus | Abridged Index Medicus
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2017, Volume 18, Issue 5, pp. 640 - 653
Summary Background Although trastuzumab plus chemotherapy is the standard of care for first-line treatment of HER2-positive advanced gastric cancer, there is... 
Hematology, Oncology and Palliative Medicine | SURVIVAL | SUPPORTIVE CARE | WEEKLY PACLITAXEL | ONCOLOGY | 2ND-LINE CHEMOTHERAPY | IRINOTECAN | LEVEL | PLUS PACLITAXEL | HER2 | CANCER | DOCETAXEL | Follow-Up Studies | Febrile Neutropenia - chemically induced | Humans | Middle Aged | Male | Stomach Neoplasms - pathology | Antineoplastic Agents - therapeutic use | Taxoids - therapeutic use | Antineoplastic Agents - adverse effects | Pneumonia - chemically induced | Aged, 80 and over | Adult | Female | Stomach Neoplasms - chemistry | Adenocarcinoma - chemistry | Taxoids - adverse effects | Antibodies, Monoclonal, Humanized - adverse effects | Maytansine - adverse effects | Bridged-Ring Compounds - therapeutic use | Antibodies, Monoclonal, Humanized - therapeutic use | Maytansine - analogs & derivatives | Anemia - chemically induced | Survival Rate | Thrombocytopenia - chemically induced | Stomach Neoplasms - drug therapy | Maytansine - therapeutic use | Adenocarcinoma - drug therapy | Adenocarcinoma - secondary | Esophagogastric Junction | Gastrointestinal Hemorrhage - chemically induced | Retreatment | Intention to Treat Analysis | Bridged-Ring Compounds - adverse effects | Aged | Receptor, ErbB-2 - analysis | Trastuzumab | Adenocarcinoma | Medical research | Chemotherapy | Clinical trials | Medicine, Experimental | Metastasis | Esophageal cancer | Cancer | Analysis | Index Medicus
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 04/2019, Volume 380, Issue 14, pp. 1326 - 1335
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 10/2018, Volume 379, Issue 16, pp. 1529 - 1539
Journal Article